Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Baccus Consulting Ltd

Baccus Consulting Ltd. is an independent communications and consultancy agency, delivering products and services to clients across the private, public and charitable sectors. With strong Scottish links and associated understanding of the Scottish policy arena, we aim to provide a comprehensive and bespoke service to clients and who need support in reaching a range of key stakeholders. We work with clients as a strategic partner, integrating with their leadership, communications and marketing teams.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Baccus Consulting Ltd
4 Queens Bay Crescent, Edinburgh, EH15 2NA, United Kingdom
+44 (0)131 669 7066
Contact Baccus Consulting Ltd
Website

 Latest Content from PMHub 

Understanding decision making in health | Pegasus

Videos and Podcasts | March 18, 2016 | Inizio

To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

An animated approach to communicating healthy messages | Pegasus

Videos and Podcasts | March 18, 2016 | Inizio

Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

Focus on multiple myeloma treatment: Witnessing a transformation

White Papers and Resources | March 15, 2016 | Blue Latitude Health

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

The ROI of user experience in pharma and healthcare: How to engage your customers

White Papers and Resources | March 14, 2016 | Blue Latitude Health

In this article, Head of Customer Experience Elisa del Galdo of Blue Latitude Health breaks down how to understand the return on investment of user experience in pharma and healthcare.

Why health psychology should inform pharma strategy

Press Releases | March 10, 2016 | Lucid Group Communications Limited

In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform...

Pegasus shortlisted for four PM Society Digital Media Awards 2016

Press Releases | March 8, 2016 | Inizio

Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016...

Why does content need a strategy?

White Papers and Resources | March 7, 2016 | Blue Latitude Health

Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy? Content Marketing...

Seven ways to make centrally-produced content fit affiliates’ needs

White Papers and Resources | March 3, 2016 | Anthill Agency

It’s common to encounter some degree of local resistance to centrally-produced sales materials. But don’t despair. A few simple content strategies can make a huge difference. Here are seven ideas...

Lucid Group celebrate 9 years of changing patients’ lives

Press Releases | March 3, 2016 | Lucid Group Communications Limited

Lucid Group had fun and games celebrating their nine year anniversary in their London offices last week. Lucid has grown from the two founders working out of a basement to...

Infographic: HCV EU

White Papers and Resources | March 3, 2016 | Inizio

Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction...